Spanish biotech SpliceBio has raised $135 million in financing that will help it move a gene-editing therapy for an inherited retinal disease (IRD) through clinical testing. SpliceBio's lead in-house ...
The content creator, who posts online as @EyeCharlene, underwent her first rhinoplasty at age 23 ...
Late last month, pharmaphorum was invited on an IDA Ireland-organised press tour of the life sciences industry in Ireland’s West, permitting an inside peek into the world-class life sciences ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Mel Plaut Mel Plaut is a writer covering pets. They have tested hundreds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results